Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Head and Neck Cancer

Free Subscription 03.08.2026 1 Am J Gastroenterol 1 Ann Otol Rhinol Laryngol 1 Ann Surg 3 Anticancer Res 1 Br J Cancer 1 Br J Oral Maxillofac Surg 2 Clin Nucl Med 1 HNO 2 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Laryngol Otol 18 Oral Oncol 4 Otolaryngol Head Neck Surg 1 PLoS One 2 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. CHATTERJEE A, Abrams JA, Stachler MD
   Biomarker Use in Barrett's Esophagus Surveillance.
   Am J Gastroenterol. 2026;121:1813-1818.
   PubMed         Abstract available
   
   

   
   Ann Otol Rhinol Laryngol

2. KANNAN V, Freeman T, Marquardt M, Herster R, et al
   A Novel 3D-Printed Simulator for Patient-Directed Home Drain Removal in Head and Neck Surgery.
   Ann Otol Rhinol Laryngol. 2026;135:692-697.
   PubMed         Abstract available
   
   

   
   Ann Surg

3. GUIDOZZI N, Chou WK, Giorgi L, Salem R, et al
   The Prognostic Impact of Lymph Node Yield Upon Survival in Esophageal Cancer Broken Down by Neoadjuvant Strategy: A Multicenter European Cohort Study.
   Ann Surg. 2026 Jul 31. doi: 10.1097/SLA.0000000000007164.
   PubMed         Abstract available
   
   

   
   Anticancer Res

4. LEITE AA, DA Silva LC, Borgato GB, Kowalski LP, et al
   Cephaeline Disrupts Cancer Stem Cell Pathways to Enhance Chemotherapy Response in Oral Squamous Cell Carcinoma Cells.
   Anticancer Res. 2026;46:4239-4250.
   PubMed         Abstract available
   
   
5. TAMURA T, Toyokawa T, Lee S, Ishidate T, et al
   Safety and Feasibility of Biweekly Divided-dose of DCF as Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
   Anticancer Res. 2026;46:4461-4469.
   PubMed         Abstract available
   
   
6. QUADT C, Tablova G, Graessle R, Gebhardt B, et al
   Management of Contralateral Neck Dissection in Ipsilateral Oropharyngeal Squamous Cell Cancer Cases.
   Anticancer Res. 2026;46:4419-4429.
   PubMed         Abstract available
   
   

   
   Br J Cancer

7. LIU C, Shen C, Hou Y, Du Y, et al
   Integrated multi-omics and single-cell analyses identify metabolic heterogeneity and therapeutic vulnerabilities in medullary thyroid cancer.
   Br J Cancer. 2026;135:546-558.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

8. CARUSO DP, Fernandes RP
   Non-initiation of adjuvant therapy in advanced cutaneous squamous cell carcinoma of the head and neck.
   Br J Oral Maxillofac Surg. 2026 Jun 13:S0266-4356(26)00158.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

9. ASGHAR N, Gill SM, Aslam E, Ilyas H, et al
   Pediatric Synchronous Nasopharyngeal Carcinoma Mimicking Refractory Hodgkin Lymphoma.
   Clin Nucl Med. 2026 Jul 28. doi: 10.1097/RLU.0000000000006638.
   PubMed         Abstract available
   
   
10. MOU L, Liu Y, Yang H, Zheng W, et al
    Combined 177Lu-FAP-2286 Therapy and Immunotherapy in Metastatic Esophageal Squamous Cell Carcinoma.
    Clin Nucl Med. 2026 Jul 28. doi: 10.1097/RLU.0000000000006591.
    PubMed         Abstract available
    
    

    
    HNO

11. BLAUROCK M, Struder D, Ulbricht S, Felser S, et al
    [Use of AI during creation of scientific reviews: the example of sarcopenia in head and neck cancer].
    HNO. 2026 Jul 27. doi: 10.1007/s00106-026-01796.
    PubMed         Abstract available
    
    

    
    Int J Cancer

12. GAI X, Huang S, Ye J, Zeng J, et al
    Effects of Hippocampal Avoidance on Anxiety in Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiotherapy: A Single-Center, Single-Arm, Prospective Clinical Trial.
    Int J Cancer. 2026 Jul 26. doi: 10.1002/ijc.70631.
    PubMed         Abstract available
    
    
13. FANG Y, Yi C, Sun R, Shen B, et al
    Global Annualized Recurrence Rates and Dynamic Risk Profiles in Head and Neck Cancer.
    Int J Cancer. 2026 Jul 26. doi: 10.1002/ijc.70675.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

14. YAMASHITA H, Sawayanagi S, Kono M, Kiritoshi T, et al
    A phase II randomized trial comparing radiation doses in concurrent chemoradiotherapy with TS-1/nedaplatin for curative treatment of newly diagnosed or recurrent esophageal cancer.
    Int J Radiat Oncol Biol Phys. 2026 Jul 31:S0360-3016(26)04067.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

15. RAJGOR A, Gill T, Aboagye E, Mill A, et al
    Impact of Socioeconomic Deprivation on Outcomes in Advanced Laryngeal Cancer: A Retrospective Regional United Kingdom Cohort Study.
    J Laryngol Otol. 2026 Jul 27:1-26. doi: 10.1017/S0022215126105520.
    PubMed        
    
    

    
    Oral Oncol

16. TOPKAN E, Selek U
    Comment on "Elective neck dissection and adjuvant therapy in N0 major salivary gland cancer: an analysis of the SEER cancer database".
    Oral Oncol. 2026;181:108091.
    PubMed        
    
    
17. SYKES J, Uribe Sanchez ED, Benito D, Danyluk A, et al
    Prognostic value of the 5-Item Modified Frailty Index in elderly patients undergoing free flap reconstruction for head and neck cancer.
    Oral Oncol. 2026;181:108088.
    PubMed         Abstract available
    
    
18. TALOR E, Lavin P, Cipriano J, Markovic D, et al
    A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial - Prognostic role of tumor PD-L1 expression.
    Oral Oncol. 2026;181:108092.
    PubMed         Abstract available
    
    
19. PLATAIS C, Clark M, Hankinson P, Mahmood H, et al
    Malignant transformation of verrucous oral potentially malignant disorders at a tertiary referral centre: A retrospective cohort study.
    Oral Oncol. 2026;180:108040.
    PubMed         Abstract available
    
    
20. STROJAN P, Zagar T, Sifrer R, Didanovic V, et al
    Primary treatment modalities and p16 status in oropharyngeal squamous cell carcinoma outcomes: a tertiary center study with propensity score analysis.
    Oral Oncol. 2026;180:108039.
    PubMed         Abstract available
    
    
21. THARIAT J, Marcy PY, Preudhomme R, Gadan C, et al
    Postoperative radiotherapy delineation after mandibular bone flap reconstruction in oral cavity and oropharyngeal cancers.
    Oral Oncol. 2026;180:108054.
    PubMed         Abstract available
    
    
22. LI Z, Yi S, Zhong Y, Wu W, et al
    Long-term outcomes, prognostic factors, and patterns of failure of postoperative adjuvant iodine-125 seed brachytherapy for parotid carcinoma: a large single-institution cohort.
    Oral Oncol. 2026;180:108057.
    PubMed         Abstract available
    
    
23. KHADERI IM, Kandahari N, Saleh AW, Hackman TG, et al
    Development of the TORS severe outcome score: a preoperative risk stratification tool for postoperative morbidity in oropharyngeal cancer.
    Oral Oncol. 2026;180:108058.
    PubMed         Abstract available
    
    
24. TAPESCU I, Brody RM, Cao AC, Le K, et al
    Predictors and outcomes of pathologic retropharyngeal lymph nodes in HPV-related oropharyngeal cancer.
    Oral Oncol. 2026;180:108056.
    PubMed         Abstract available
    
    
25. LU RJ, Dunn L, Tam K, Starc MT, et al
    Characterization of response-adapted surgery following neoadjuvant systemic therapy in oral cavity cancer.
    Oral Oncol. 2026;180:108060.
    PubMed         Abstract available
    
    
26. CHANG A, Jacoby D, Lin A, Lukens JN, et al
    Lymphedema therapy in head & neck cancer with carotid stenosis: a systematic review and care pathway.
    Oral Oncol. 2026;180:108063.
    PubMed         Abstract available
    
    
27. ESTEVES-PEREIRA TC, Carvalho AL, Lauby-Secretan B, Martinez-Ramirez J, et al
    Implementation-focused consensus recommendations for oral cavity cancer prevention and early detection in Latin America and the Caribbean: A Delphi study.
    Oral Oncol. 2026;180:108065.
    PubMed         Abstract available
    
    
28. NGO DQ, Anuwong A, Le DT, Ngo QX, et al
    Technical and therapeutic evaluation of endoscopic treatment of early papillary thyroid cancer through oral vestibular approach.
    Oral Oncol. 2026;180:108061.
    PubMed         Abstract available
    
    
29. FU QY, Wang XX, Yang Y, Zeng J, et al
    A salivary protein panel for detecting malignant transformation of oral leukoplakia.
    Oral Oncol. 2026;180:108064.
    PubMed         Abstract available
    
    
30. ATYEO N, Warner B, Chiorini JA
    Aquaporin-1 gene therapy as a novel method to treat radiation-induced salivary gland damage: The case for adeno-associated virus vectors.
    Oral Oncol. 2026;180:108071.
    PubMed         Abstract available
    
    
31. YAMIN T, Bergman D, Bartal K, Tiomkin E, et al
    The gender gap in HPV Literacy: A Cross-Sectional study of patient awareness of HPV-Related oropharyngeal carcinoma in men in the vaccine era.
    Oral Oncol. 2026;180:108075.
    PubMed         Abstract available
    
    
32. GARCIA-AGULLO J, Santos V, Garcia-Mayea Y, de Luxan-Delgado B, et al
    NGFR expression predicts tumor recurrence in radiotherapy/chemoradiotherapy-treated HPV-negative pharyngeal squamous cell carcinoma.
    Oral Oncol. 2026;180:108080.
    PubMed         Abstract available
    
    
33. LI W, Fang S, Cao Y, Wang Y, et al
    A bifunctional fusion protein simultaneously targeting PD-L1 and TGF-beta1 (SHR1701) enhanced preclinical antitumor activity in oral squamous cell carcinoma.
    Oral Oncol. 2026;180:108078.
    PubMed         Abstract available
    
    

    
    Otolaryngol Head Neck Surg

34. RAVIN E, Alshalalfa M, Jiang R, Hao Y, et al
    The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules.
    Otolaryngol Head Neck Surg. 2026;175:343-349.
    PubMed         Abstract available
    
    
35. YI J, Cao L, Zhang JH, Bai Y, et al
    Evaluation of Prognostic Factors in Adult Sinonasal Rhabdomyosarcoma With Consideration of Resection Status.
    Otolaryngol Head Neck Surg. 2026;175:394-401.
    PubMed         Abstract available
    
    
36. YANG SW
    Image-Guided Excision of Oral Leukoplakia Using Narrow-Band Imaging Illumination and Two-Stage Local Anesthesia.
    Otolaryngol Head Neck Surg. 2026;175:492-494.
    PubMed         Abstract available
    
    
37. IJTSMA HH, van Dijk SPJ, Cunningham CE, van Kemenade FJ, et al
    The Role of Thyroidectomy in the Management of Thyroglossal Duct Carcinoma: A Systematic Review.
    Otolaryngol Head Neck Surg. 2026;175:271-280.
    PubMed         Abstract available
    
    

    
    PLoS One

38. WANG S, Zhang L, Shi G, Liu Z, et al
    PM-DUnet: Fusing long-range dependencies and attention in a dual-U architecture for thyroid nodule segmentation.
    PLoS One. 2026;21:e0353684.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

39. YANG Q, Fang J, Chen C, Zhang C, et al
    The TFDP2-PDK3 axis drives glucose metabolic reprogramming to promote radioresistance in nasopharyngeal carcinoma.
    Radiother Oncol. 2026 Jul 28:111708. doi: 10.1016/j.radonc.2026.111708.
    PubMed         Abstract available
    
    
40. BECHERINI C, Banini M, Blanchard P, Brana I, et al
    Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.
    Radiother Oncol. 2026;223:111711.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum